Skip to main content

Mouse VEGF-D Biotinylated Antibody

R&D Systems, part of Bio-Techne | Catalog # BAF469

R&D Systems, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
BAF469

Key Product Details

Species Reactivity

Mouse

Applications

ELISA Detection (Matched Antibody Pair), Western Blot

Label

Biotin

Antibody Source

Polyclonal Goat IgG

Product Specifications

Immunogen

E. coli-derived recombinant mouse VEGF-D
Phe98-Ser206
Accession # P97946

Specificity

Detects mouse VEGF-D in ELISAs and Western blots. In sandwich immunoassays, less than 75% cross-reactivity with recombinant human (rh) VEGF-D is observed and less than 0.1% cross-reactivity with recombinant mouse (rm) VEGF, rmVEGF-B, and rhVEGF-C is observed.

Clonality

Polyclonal

Host

Goat

Isotype

IgG

Applications for Mouse VEGF-D Biotinylated Antibody

Application
Recommended Usage

Western Blot

0.1 µg/mL
Sample: Recombinant Mouse VEGF-D (Catalog # 469-VD)

Mouse VEGF-D Sandwich Immunoassay

ELISA Detection (Matched Antibody Pair)
Recommended Concentration: 0.1-0.4 µg/mL
Use in combination with these reagents:
  • Capture Reagent: Mouse VEGF-D Antibody (Catalog # MAB469)
  • Standard: Recombinant Mouse VEGF-D Protein (Catalog # 469-VD)
Please Note: Optimal dilutions of this antibody should be experimentally determined.

Formulation, Preparation, and Storage

Purification

Antigen Affinity-purified

Reconstitution

Reconstitute at 0.2 mg/mL in sterile PBS.

Reconstitution Buffer Available:
Size / Price
Qty
Loading...

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with BSA as a carrier protein.

Shipping

The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: VEGF-D

Vascular endothelia growth factor D (VEGF-D), also known as c-fos-induced growth factor (FIGF), is a secreted glycoprotein of the VEGF/PDGF family. VEGFs regulate angiogenesis and lymphangiogenesis during development and tumor growth, and are characterized by eight conserved cysteine residues that form a cysteine-knot structure (1‑3). VEGF-C and VEGF-D, which share 23% amino acid (aa) sequence identity, are uniquely expressed as preproproteins that contain long N- and C-terminal propeptide extensions around the VEGF homology domain (VHD) (1, 2). Proteolytic processing of either 358 aa or 326 aa splice forms of mouse VEGF-D preproprotein creates a secreted proprotein. Further processing by extracellular serine proteases, such as plasmin or furin-like proprotein convertases, forms mature VEGF-D consisting of non-covalently linked 42 kDa homodimers of the 117 aa VHD (4‑7). Mature mouse VEGF-D shares 94%, 99%, 93%, 91% and 89% aa identity with the VHD of human, rat, equine, canine and bovine VEGF-D, respectively. It is expressed in adult lung, heart, muscle, and small intestine, and is most abundantly expressed in fetal lungs and skin (1 - 4). Mouse and human VEGF-D are ligands for VEGF receptor 3 (VEGF-R3, also called Flt-4) that are active across species and show enhanced affinity when processed (8). Unlike human VEGF-D, which is also a ligand for VEGF-R2 (also called Flk-1 or KDR), mouse VEGF-D does not bind to VEGF-R2 (8). VEGF-R3 is strongly expressed in lymphatic endothelial cells and is essential for regulation of the growth and differentiation of lymphatic endothelium (1, 2). While VEGF-C is the critical ligand for VEGF-R3 during embryonic lymphatic development, VEGF-D is most active in neonatal lymphatic maturation and bone growth (9‑11). Both promote tumor lymphangiogenesis (12). Consonant with their activity on VEGF receptors, binding of VEGF-C and VEGF-D to neuropilins contributes to VEGF-R3 signaling in lymphangiogenesis, while binding to integrin alpha9 beta1 mediates endothelial cell adhesion and migration (13, 14).

References

  1. Roy, H. et al. (2006) FEBS Lett. 580:2879.
  2. Otrock, Z.H. et al. (2007) Blood Cells Mol. Dis. 38:258.
  3. Orlandini, M. et al. (1996) Proc. Natl. Acad. Sci. USA 93:11675.
  4. Stacker, S.A. et al. (1999) J. Biol. Chem. 274:32127.
  5. McColl, B.K. et al. (2003) J. Exp. Med. 198:863.
  6. McColl, B.K. et al. (2007) FASEB J. 21:1088.
  7. Baldwin, M.E. et al. (2001) J. Biol. Chem. 276:44307.
  8. Baldwin, M.E. et al. (2001) J. Biol. Chem. 276:19166.
  9. Baldwin, M.E. et al. (2005) Mol. Cell. Biol. 25:2441.
  10. Karpanen, T. et al. (2006) Am. J. Pathol. 169:708.
  11. Orlandini, M. et al. (2006) J. Biol. Chem. 281:17961.
  12. Stacker, S.A. et al. (2001) Nature Med. 7:186.
  13. Karpanen, T. et al. (2006) FASEB J. 20:1462.
  14. Vlahakis, N.E. et al. (2005) J. Biol. Chem. 280:4544.

Long Name

Vascular Endothelial Growth Factor D/cFos-induced Growth Factor

Alternate Names

FIGF, VEGFD

Entrez Gene IDs

2277 (Human); 14205 (Mouse)

Gene Symbol

VEGFD

UniProt

Additional VEGF-D Products

Product Documents for Mouse VEGF-D Biotinylated Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Mouse VEGF-D Biotinylated Antibody

For research use only

Loading...
Loading...
Loading...
Loading...